Quality of life in cutaneous T cell lymphoma patients treated with the anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: results from MAVORIC.
Porcu, P Hudgens, S Quaglino, P Floden, L Tsianakas, A Leoni, M Dale, S Duvic, M
Porcu, P
Hudgens, S
Quaglino, P
Floden, L
Tsianakas, A
Leoni, M
Dale, S
Duvic, M
Citations
Altmetric:
Abstract
Affiliation
Description
Date
2018
Publisher
Collections
Keywords
Type
Meetings and Proceedings
Citation
Quality of life in cutaneous T cell lymphoma patients treated with the anti-CCR4 monoclonal antibody mogamulizumab versus vorinostat: results from MAVORIC. 2018, 101 Eur J Cancer